高级检索
王广平, 石晟怡, 丁静. 基于药物短缺问题的医药产业结构调整路径研究[J]. 应用技术学报, 2020, 20(3): 242-249. DOI: 10.3969/j.issn.2096-3424.2020.03.007
引用本文: 王广平, 石晟怡, 丁静. 基于药物短缺问题的医药产业结构调整路径研究[J]. 应用技术学报, 2020, 20(3): 242-249. DOI: 10.3969/j.issn.2096-3424.2020.03.007
WANG Guangping, SHI Shengyi, DING Jing. Research on the Structure Adjustment Path of China Pharmaceutical Industry Based on Drug Shortage[J]. Journal of Technology, 2020, 20(3): 242-249. DOI: 10.3969/j.issn.2096-3424.2020.03.007
Citation: WANG Guangping, SHI Shengyi, DING Jing. Research on the Structure Adjustment Path of China Pharmaceutical Industry Based on Drug Shortage[J]. Journal of Technology, 2020, 20(3): 242-249. DOI: 10.3969/j.issn.2096-3424.2020.03.007

基于药物短缺问题的医药产业结构调整路径研究

Research on the Structure Adjustment Path of China Pharmaceutical Industry Based on Drug Shortage

  • 摘要: 药品短缺是全球性挑战。我国药物短缺问题影响了供给侧改革、政府机构改革、仿制药一致性再评价、"两票制"等政策的效果。采用Panel Data模型进行药物短缺的产业结构调整实证研究,结果显示下游产业的市场集中度不高、生产方式粗放、上下游产业交易成本过高,需加快结构调整和转型升级,促进药物短缺问题解决。药物短缺问题的产业结构调整路径包括"医联体"用药结构调整、网络信息搜索、国有企业引领、技术创新带动等。

     

    Abstract: Drug shortage is a global challenge. Drug shortage problem reflects the policy effects of supply-side reform, government institutional reforming, generic drug consistency evaluation, and two-vote system. This paper conducts an empirical study on the pharmaceutical industrial structure adjustment of drug shortage by the Panel Data model. The results show that the downstream industry's lower market concentration and extensive production method, the higher transaction costs between upstream and downstream industries, what accelerate structural adjustment and upgrading, and solve the drug shortage problem. The industrial structure adjustment path of drug shortage includes the drug structure adjustment of medical institutions, network information searching, leading of state-owned enterprises, technological innovation, and so on.

     

/

返回文章
返回